🔴 PMN Dips 5.1% Amidst Broader Market Sell-off, Despite HC Wainwright & Co. Buy Rating Reiteration

PMN is trading 5.1% down at $10.15 today, pulling back from a multi-day climb, while major U.S. indices are broadly lower.

• The decline comes despite H.C. Wainwright & Co. reiterating a 'Buy' rating for ProMIS Neurosciences (PMN) with an $18.00 price target today, June 24, 2026.
• Contrary to earlier reports, broader market indices, including the S&P 500 and Nasdaq, are trading lower, affecting investor sentiment.
• The stock had closed at $10.69 on June 23, 2026, following several days of gains.